Because MGMT is unmethylated in 60% of IDH-wildtype GBM, a strategy to chemosensitize GBM using DAC, so that TMZ has wider utility in this subtype, could have a large impact in the poorest prognosis patients. The gene discussed is MGMT; the disease is glioblastoma.